Dow Up0.76% Nasdaq Up0.69%

Quest Diagnostics Inc. (DGX)

63.76 Up 0.88(1.40%) Oct 24, 4:02PM EDT
|After Hours : 63.76 0.00 (0.00%) Oct 24, 4:57PM EDT
ProfileGet Profile for:
Quest Diagnostics Inc.
3 Giralda Farms
Madison, NJ 07940
United States - Map
Phone: 973-520-2700

Index Membership:N/A
Industry:Medical Laboratories & Research
Full Time Employees:41,000

Business Summary 

Quest Diagnostics Incorporated provides diagnostic testing information services in the United States and internationally. The company operates in two businesses, Diagnostic Information Services and Diagnostic Solutions. It offers clinical testing services, such as routine testing, gene-based and esoteric testing, anatomic pathology services, and drugs-of-abuse testing, as well as related services and insights; laboratory testing services for new drugs, vaccines, and medical devices; and risk assessment services for the life insurance industry. The company also develops, manufactures, and markets diagnostic products, including Simplexa molecular chemistries for testing infectious disease and hospital-acquired infections; HerpeSelect HSV serology; and DxSelect IFA and ELISA products for testing infectious diseases. In addition, it provides molecular diagnostic products in various segments, such as HIV-1 drug resistance testing under the ViroSeq brand name; and reproductive genetics and transplantation under the brand names of Atria and AlleleSeqr. Further, the company offers Care360 EHR, a solution that allows doctors to electronically create, manage, and distribute patient encounter notes, including vital signs and progress notes; and ChartMaxx, an electronic document management system for hospitals. The company offers its diagnostic information services to patients, physicians, hospitals, integrated delivery networks, health plans, employers, and others through a network of laboratories, patient service centers, and phlebotomists in physician offices. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Madison, New Jersey.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Quest Diagnostics Inc.

Corporate Governance 
Quest Diagnostics Inc.’s ISS Governance QuickScore as of Oct 1, 2014 is 3. The pillar scores are Audit: 1; Board: 6; Shareholder Rights: 5; Compensation: 3.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
Mr. Stephen H. Rusckowski , 57
Chief Exec. Officer, Pres, Director and Member of Exec. Committee
Mr. Mark J. Guinan , 52
Chief Financial Officer and Sr. VP
Ms. Catherine T. Doherty , 51
Sr. VP of Clinical Franchises
Dr. Jon R. Cohen M.D., 59
Chief Medical Officer and Sr. VP of Hospital Services
Mr. John B. Haydon , 52
VP of Joint Ventures and Strategic Programs
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders